Corvia’s Atrial Shunt shows significant benefit in 50% of study participants
US-based medical equipment manufacturer Corvia Medical has unveiled analyses showing positive results for its Atrial Shunt, from Phase 3 REDUCE LAP-HF II trial in heart failure patients with